DIRECTORY
BIOTECH
Pharmaclient

   

Quick Click ! Monthly news Home-Site Contactexpress Faqs Legends Search Companies Events Environment Memories Home-Biotech

AbAg | Abcys | AB Science | Adocia | Advicenne Pharma | Affichem | Agate Bioservices | Aisa Therapeutics | Alfact Innovation | AliX | Alizé Pharma | Alphelys | Ambiotis | Anaconda Pharma | Aptys Pharmaceuticals | Ariana Pharmaceuticals | Atlantic Bone Screen | Aureus Pharma | B Cell Design | BioAlliance Pharma | Biocortech | BioCydex | BioMedical Diagnostics | Biométhodes | Biom'up | BioProtein Technologies | BioQuanta | BioSystems International | BMSystems (Bio-modeling) | BT Pharma | Cellectis | Cellial Technologies | CellVax | CellVir | Cerenis Therapeutics | Cezanne | CliniGenetics | Covalab | Cytheris | Cytomics | DBV Technologies | Diatos | DNA Therapeutics | Domain Therapeutics | Dynabio | Endotis Pharma | Epixis | ERYtech Pharma | Exonhit | Eye Tech Care | Flamel Technologies | Fluofarma | Fovea Pharmaceuticals | GemacBio | Genepep | Genewave | Genfit | GenOdyssee | Genomic Vision | GenoSafe | GenoScience Pharma | Genoscreen | GenOway | GTP Technology | Helios Biosciences | Hybrigenics | Hyphen BioMed | Imagene | ImmunId | Immutep | Imstar | In-Cell-Art | Indicia Biotechnology | Innate Pharma | InnaVirVax | IntegraGen | Ipsogen | I-Stem | Ivagen | Karcinolys | Keosys | LibraGen | Magnisense | Mapreg | MAT Biopharma | Mauna Kea Technologies | Medesis Pharma | Mellitech | Meristem Therapeutics | MicroBioChips | MilleGen | MitoProd | Murigenetics | Mutabilis | Myosix | NanoBiotix | Nautilus Biotech | Neorphys | Neovacs | Netris-Pharma | Neuronax | NicOx | Nokad | Nova Decision | Novagali | Novexel | NovoCIB | Novotec | ObeTherapy | Oligovax | Oncodesign | Oroxcell | Oxincell | Palumed | PharmaLeads | Pharmaxon | Pharnext | PhenoPro | Pherecydes Pharma | PolyIntell | PraXcell | Proteogenix | Protéus | Protexel | PX’Therapeutics | Quantum Genomics | Rhenovia Pharma | ScarCell Therapeutics | Sepal Pharma | Serial Genetics | ShigaMediX | Sisène Biotechnologies | Skuld-Tech | Synapcell | Synprosis | Tc Land Expression | Theraclion | Theraptosis | TheraVectys | Transgene | Trophos | TxCell | UroGene | UROsphere | Urrma | Vaxon Biotech | Vectalys | VigiCell | Vivalis | XenTech |

* IPSOGEN *

1999 - Méditerranée
Marseille
www.ipsogen.com

Discovery, Diagnostics
Key words: Assays, Molecular expression, Biomarker, Blood cancer, Leukemia
Mission: to develop and market molecular diagnostic tests designed to map diseases in order to guide patient and oncologists decision along their complex therapeutic path
Clients: Research labs, Prescribers
infos@ipsogen.com

Identity
TYPE/MANAGEMENT/INVESTORSFINANCES/STATUS

Personal venture |
Managing Dir.: Fert (Vincent) [co-founder, born 1959, Ms. immunology, ex-Immunotech, Beckman Coulter]
Sc.Dir.: Hermitte (Fabienne) [co-founder, Ph.D., INA, ex-Rhône Poulenc, CNRS]
Oper.Dir.: Debono (Stéphane) [born 1975, ESIM, ex-Immunotech, Beckman Coulter]
Fin.Dir.: Piot (Stanislas) [ex-Natixis, Crédit Lyonnais, Oddo, Worms]
BusDev:
Financers: Samenar (Caisse d'Epargne), Institut Paoli-Calmettes, Société Générale A.M., Matignon Technologies, Innovéris, Connecticut Innovations, Viveris, Natixis, Octalia, Public

Turnover (M€) : 2.0 (2007)
Total funding (M€) : 21.8
Last funding (M€) : 11.8
Focus : Cancers
Position : Trade
Company confirm : none

History
DATEMILESTONETYPETIME
2008 .11 Launch of MapQuant Dx, a new test to determine tumor HER2 status and guide Herceptin prescription in breast cancer (Europe) MKTG [9 years]
2008 .08 Licensing-out to Quest Diagnostics for the use of the JAK2 V617F mutation into Quest kits LICOUT [9 years]
2008 .06 Listing on Alternext : 11.8 M€, i.e. 35% of shares (oversubscribed) PBO [9 years]
2007 .11 3rd round-financing : 2.0 M€, by Connecticut Innovations, and previous shareholders RFINC [8 years]
2005 .03 Set-up of US subsidiary (operations) in Connecticut State ORGC [6 years]
2005 .02 2nd round-financing : 3.5 M€, by previous shareholders RFINB [6 years]
2001 .07 1st round-financing : 4.5 M€, led by Société Générale A.M., with Matignon Technologies, Innovéris RFINA [2 years]
1999 .09 Company founded by Vincent Fert (CEO), Stéphane Debono, Fabienne Hermitte ORGF [0 year]

Actualisation / Updating: 31-Oct-2008

Pharmaclient est le site-conseil de la Valorisation Client en Pharma...
Pour toute Mission, Inscription à la Pharmagalerie, Insertion dans la base Biotech, ou Question: CONTACT
Pour retourner à la page d'accueil Biotech: BIENVENUE !

Haut de page :

Copyright J.H. Huber, Pharmaclient 2001-2008.

Pharmaclient, le site de la valorisation client en Pharma, est la vitrine des activités de conseil de Jean Huber: Stratégie, Communication, Relation Client en Pharma.